Alyssa Dolan is an associate in the New York office of Latham & Watkins and a member of the Intellectual Property Litigation Practice.
Alyssa represents clients in intellectual property litigation, with a focus on the life sciences industry.
Alyssa has experience at all phases of litigation, including pre-filing investigations, fact and expert discovery, witness preparation, discovery and dispositive motion practice, trial preparation, trial and post-trial practice, and appellate practice. She has worked on intellectual property matters in federal district courts, the United States Court of Appeals for the Federal Circuit, the Patent Trial and Appeal Board, and arbitration.
Prior to joining Latham, Alyssa served as a law clerk for the Honorable Tiffany P. Cunningham of the United States Court of Appeals for the Federal Circuit. She also previously worked at a major international law firm, where she represented clients in intellectual property litigation.
Alyssa earned her JD from Georgetown University Law Center, where she served as the Executive Editor of the Georgetown Food and Drug Law Journal, and her BS in Chemistry from Fordham University.
Experience
Alyssa’s experience includes representing:
A biotechnology company in patent litigation concerning its antibody treatment for COVID-19
A medical device company in multi-patent and trade secret litigation concerning spinal cord stimulation and implantable medical device technology to treat pain*
A life science company in multiple patent suits concerning replacement Factor VIII products used to treat hemophilia*
A biopharmaceutical company in trademark and breach of contract litigation*
*Matter handled prior to joining Latham.
Qualifications
Bar Qualification
New York
Education
JD, Georgetown University Law Center, 2019 magna cum laude, Order of the Coif
BS in Chemistry & Bioethics, Fordham University, 2016 summa cum laude
Latham's Intellectual Property Litigation Practice was honored for securing exceptional trial results this year, including a complete jury trial win for Sarepta Therapeutics and an ITC trial win for Netgear.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.